Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine and Naloxone in Motivation and Effort Management
NCT02267304Phase 2Completed
- Sponsor
- Inserm
- Start
- Oct 2013
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of morphine, naloxone, sponsored by Inserm. Started Oct 2013; status: completed.
02
Drugs
morphinenaloxone
Beyond the preview
Go deeper on NCT02267304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02267304.